Regulation of and by Pharmacists in the Netherlands and Belgium PDF Download
Are you looking for read ebook online? Search for your book and save it on your Kindle device, PC, phones or tablets. Download Regulation of and by Pharmacists in the Netherlands and Belgium PDF full book. Access full book title Regulation of and by Pharmacists in the Netherlands and Belgium by Niels Philipsen. Download full books in PDF and EPUB format.
Author: Niels Philipsen Publisher: Intersentia nv ISBN: 9050953514 Category : Pharmacists Languages : en Pages : 211
Book Description
This book examines the regulation of pharmacists in the Netherlands and Belgium from the perspective of law and economics. It starts with an extensive and accessible overview of the economic literature with respect to the regulation (including self-regulation) of liberal professions. Subsequently, this book analyses the extent to which the current regulation of Dutch and Belgian pharmacists serves the public interest and the extent to which this regulation is a result of rent-seeking behaviour by private interest groups. The author concludes that some regulation, notably with respect to advertising, design of the pharmacy, establishment of pharmacies and drug prices, does not seem to serve the public interest. Moreover, he criticises the regulation of reimbursement for the pharmacist, which in both countries is still linked to the phar-macists monopoly in the distribution of drugs, despite new tasks of the pharmacist in the field of pharmaceutical care. In addition to a theoretical analysis, the author carries out an empirical research of rent-seeking behaviour in the pharmaceutical market. Although the book studies the situation in the Netherlands and in Belgium, its conclusions will certainly apply to other countries and other professions. The book will therefore be of interest to all economists, lawyers and practitioners interested in regulation of the liberal professions as well as practitioners and academics working in the field of health care.
Author: Niels Philipsen Publisher: Intersentia nv ISBN: 9050953514 Category : Pharmacists Languages : en Pages : 211
Book Description
This book examines the regulation of pharmacists in the Netherlands and Belgium from the perspective of law and economics. It starts with an extensive and accessible overview of the economic literature with respect to the regulation (including self-regulation) of liberal professions. Subsequently, this book analyses the extent to which the current regulation of Dutch and Belgian pharmacists serves the public interest and the extent to which this regulation is a result of rent-seeking behaviour by private interest groups. The author concludes that some regulation, notably with respect to advertising, design of the pharmacy, establishment of pharmacies and drug prices, does not seem to serve the public interest. Moreover, he criticises the regulation of reimbursement for the pharmacist, which in both countries is still linked to the phar-macists monopoly in the distribution of drugs, despite new tasks of the pharmacist in the field of pharmaceutical care. In addition to a theoretical analysis, the author carries out an empirical research of rent-seeking behaviour in the pharmaceutical market. Although the book studies the situation in the Netherlands and in Belgium, its conclusions will certainly apply to other countries and other professions. The book will therefore be of interest to all economists, lawyers and practitioners interested in regulation of the liberal professions as well as practitioners and academics working in the field of health care.
Author: Michael Faure Publisher: Edward Elgar Publishing ISBN: 1781003246 Category : Law Languages : en Pages : 425
Book Description
This book focuses on experiences with the Anti-Monopoly Law (AML) of 2007 in China. It uses carefully-chosen case studies to examine how the competition authorities in China discuss cases and how they use economic reasoning in their decision-making process. Bringing together comparative perspectives, the expert contributors discuss the practice of the Anti-Monopoly Law in China from the viewpoints of European and American competition policy. Several very current topics are given specific attention, including enforcement, the role of the state, how to define the relevant market and how to apply the AML to regulated industries. The book also indicates the scope for mutual learning on how to improve the AML. The Chinese Anti-Monopoly Law will appeal to competition lawyers, attorneys-at-law dealing with economic law generally, civil servants and policy makers, comparative lawyers and social scientists with an interest in developments in China.
Author: Tinne Heremans Publisher: Bloomsbury Publishing ISBN: 1847318800 Category : Law Languages : en Pages : 229
Book Description
Professional services are a key component of the EU internal market economy yet also significantly challenge the legal framework governing this internal market. Indeed, specific professional regulatory structures, which are often the result of a blend of government and self-regulation, hold clear potential for conflict with EU free movement and competition law rules. Hence this book looks at the manner in which both free movement and competition laws might apply to such self- and co-regulatory set-ups, and at the leeway given to quality considerations (apparently) conflicting with free movement or competition objectives. In addition, since court action will seldom suffice to genuinely integrate a market, the book also explores those instruments of EU secondary legislation that are likely to impact the most on the provision of professional services. However, the book goes beyond a mere inventory to ask how EU Internal Market policy could contribute to the optimal legal environment for professional services. A law and economics analysis is employed to investigate the need for specific professional rules, the preferred type of regulator (self-, co- or government regulation), and the level - national and/or European - at which regulation should be adopted. As becomes clear, the story of the market for professional services is one of market and government failure; the author is thus left to compare imperfect situations where market failures compete with rent-seeking efforts, the tendency towards over-centralisation and national protectionism. This book offers both an in-depth legal analysis of the EU framework as it applies to professional services as well as a more normative evaluation of this framework based on insights from law and economics scholarship. It will therefore be a valuable resource for all practitioners, policy-makers and academics dealing with professional services, as well as, more generally, with questions of quality and self-regulation.
Author: Stefan E. Weishaar Publisher: Edward Elgar Publishing ISBN: 1785368540 Category : Business & Economics Languages : en Pages : 297
Book Description
With the Chinese government planning a comprehensive and detailed reform of regulatory law, the European experience is likely to contribute significantly. This timely book analyses comparative Chinese and EU regulatory reform from a Law and Economics perspective.
Author: Michael Faure Publisher: Routledge ISBN: 1134623070 Category : Business & Economics Languages : en Pages : 253
Book Description
This book, from a top international group of scholars, explores the ways in which economic tools can be used to improve the quality of regulation in general and legislative tools in particular. As the role of law becomes increasingly important in China, the question arises of how effective regulatory and legislative tools can be developed to accompany the Chinese evolution towards a welfare state. China therefore provides a unique case study for scholars and policymakers interested in examining how regulation can play a role in promoting sustainable development. Economics and Regulation in China goes beyond traditional economic analysis of law by focusing specifically on the question of how economic tools can guide the quality of legislation. To this end, the book centres in on three areas: regulation as a tool of economic growth, competition policy and environmental policy. Not only are these three domains of great importance for China, but they are also relevant for a broad scholarship interested in the economic analysis of law. This volume contributes to discussions on how ex-ante evaluation of legislative proposals and ex-post analysis can increase the effectiveness and efficiency of regulation, using economic tools, offering insights that go beyond the particular case of China. The analysis offered by this book makes it an invaluable resource for academics and policymakers alike.
Author: Niels Philipsen Publisher: Springer ISBN: 3662482738 Category : Law Languages : en Pages : 321
Book Description
This book examines the relationship between regulation and market integration, with a special focus on China. It pursues a Law and Economics and Comparative Law approach (China and EU) to analyze the current obstacles to market integration and domestic economic growth in China. Topics covered at the national level include competition law, public procurement rules and financial regulation. At the regional and local level, this book addresses questions related to administrative monopolies, self-regulation, legal services markets, and environmental law.
Author: Mossialos, Elias Publisher: McGraw-Hill Education (UK) ISBN: 0335214657 Category : Education Languages : en Pages : 390
Book Description
"This thoughtful and comprehensive book represents the best work I have seen on the current situation concerning medication policies in the EU. It is not just that this is a very up-to-date compendium of facts and data across a wide variety of domains that impact on pharmaceutical regulation. The book is also strong on analysis of those facts as well." Jerry Avorn, Harvard Medical School. "This book offers a comprehensive examination of approaches to manage pharmaceutical expenditures in Europe. It is a must-read for those who seek to understand and navigate the changing regulatory environment for medicines in the European Union." Bernie O'Brien, McMaster University, Canada. The rising cost of pharmaceutical expenditures in many European countries is of concern to governments required to make effective use of health care budgets. Taking a broad perspective that encompasses institutional, political and supranational aspects of pharmaceutical regulation, this book examines approaches used to manage pharmaceutical expenditure across Europe and what impact these strategies have had on efficiency, quality, equity and cost of pharmaceutical care.Regulating Pharmaceuticals in Europe is an important book for students of health policy, regulation and management, and for health managers and policy makers. The editors: Elias Mossialos is Brian Abel-Smith Professor of Health Policy at the London School of Economics and Political Science and a Research Director of the European Observatory on Health Systems and Policies. Monique Mrazek is a Health Economist (Europe and Central Asia region) for the World Bank and formerly a Research Officer in Health Economics for the European Observatory on Health Systems and Policies. Tom Walley is Professor of Clinical Pharmacology at the University of Liverpool and Director of the UK National Health Technology Assessment Programme. Contributors:Julia Abelson, Christa Altenstetter, Vittorio Bertele’, Christine Bond, Marcel L. Bouvy, Colin Bradley, Steve Chapman, Anna Dixon, Michael Drummond, Pierre Durieux, Edzard Ernst, Armin Fidler, Eric Fortess, Richard Frank, Silvio Garattini, Leigh Hancher, Ebba Holme Hansen, Steve Hudson, Kees de Jonchere, Panos Kanavos, Sjoerd Kooiker, Jean-Marc Leder, Graham Lewis, Donald W. Light, Alistair McGuire, Elias Mossialos, Monique Mrazek, Maria Pia Orru', Govin Permanand, Guenka Petrova, Munir Pirmohamed, Dennis Ross-Degnan, Frans Rutten, Steven Soummerai, David Taylor, Sarah Thomson, Tom Walley.
Author: John Griffiths Publisher: Bloomsbury Publishing ISBN: 1847314309 Category : Law Languages : en Pages : 644
Book Description
This book is a successor to J Griffiths, A Bood and H Weyers, Euthanasia and Law in the Netherlands (Amsterdam University Press 1998) which was widely praised for its thoroughness, clarity, and accuracy. The new book emphasises recent legal developments and new research, and has been expanded to include a full treatment of Belgium, where since 2002 euthanasia has also become legal. The book also includes descriptions written by local specialists of the legal situation and what is known about actual practice in a number of other European countries (England and Wales, France, Italy, Scandinavia, Spain, Switzerland). The book strives for as complete and dispassionate a description of the situation as possible. It covers in detail: - the substantive law applicable to euthanasia, physician-assisted suicide, withholding and withdrawing treatment, use of pain relief in potentially lethal doses, palliative and terminal sedation, and termination of life without a request (in particular in the case of newborn babies); -the process of legal development that has led to the current state of the law; -the system of legal control and its operation in practice; -the results of empirical research concerning actual medical practice. A concluding part deals with some general questions that arise out of the material presented: Is the legalisation of euthanasia an example of the decline of law or should it, on the contrary, be seen as part and parcel of the increasing juridification of the doctor-patient relationship? Does the Dutch experience with legalised euthanasia support the idea of a 'slippery slope' toward a situation in which life-especially of the more vulnerable members of society-is less effectively protected? Is it possible to explain and to predict when a society will decide to legalise euthanasia?
Author: Stuart Anderson Publisher: McGill-Queen's Press - MQUP ISBN: 0228021596 Category : History Languages : en Pages : 228
Book Description
The word "pharmacopoeia" has come to have many meanings, although it is commonly understood to be a book describing approved compositions and standards for drugs. In 1813 the Royal College of Physicians of London considered a proposal to develop an imperial British pharmacopoeia – at a time when separate official pharmacopoeias existed for England, Scotland, and Ireland. A unified British pharmacopoeia was published in 1864, and by 1914 it was considered suitable for the whole Empire. Pharmacopoeias, Drug Regulation, and Empires traces the 350-year development of officially sanctioned pharmacopoeias across the British Empire, first from local to national pharmacopoeias, and later to a standardized pharmacopoeia that would apply throughout Britain’s imperial world. The evolution of British pharmacopoeias and the professionalization of medicine saw developments including a transition from Galenic principles to germ theory, and a shift from plant-based to chemical medicines. While other colonial powers in Europe usually imposed metropolitan pharmacopoeias across their colonies, Britain consulted with practitioners throughout its Empire. As the scope of the pharmacopoeia widened, the process of agreeing upon drug standardization became more complex and fraught. A wide range of issues was exposed, from bioprospecting and the inclusion of indigenous medicines in pharmacopoeias, to adulteration and demands for the substitution of pharmacopoeial drugs with locally available ones. Pharmacopoeias, Drug Regulation, and Empires uses the evolution of an imperial pharmacopoeia in Britain as a vehicle for exploring the hegemonic power of European colonial powers in the medical field, and the meaning of pharmacopoeia more broadly.
Author: Niels Philipsen
Author: Niels Philipsen
Author: Michael Faure
Author: Tinne Heremans
Author: Stefan E. Weishaar
Author: Michael Faure
Author: Niels Philipsen
Author: Mossialos, Elias
Author: John Griffiths
Author: 
Author: Stuart Anderson